Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 580

1.

Co-trending of parathyroid hormone and phosphate in patients receiving hemodialysis.

Block G, Do TP, Collins AJ, Cooper KC, Bradbury BD.

Clin Nephrol. 2016 Mar;85(3):142-51. doi: 10.5414/CN108629.

PMID:
26784912
2.

Treatment of Secondary Hyperparathyroidism: Results of a Phase 2 Trial Evaluating an Intravenous Peptide Agonist of the Calcium-Sensing Receptor.

Bushinsky DA, Block GA, Martin KJ, Bell G, Huang S, Sun Y, Spiegel DM, Walsh L, Mix TC, Kewalramani R.

Am J Nephrol. 2015;42(5):379-88. doi: 10.1159/000442754. Epub 2015 Dec 19.

PMID:
26684933
3.

Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis.

Parfrey PS, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Chertow GM.

Clin J Am Soc Nephrol. 2015 Nov 27. pii: CJN.06370615. [Epub ahead of print]

PMID:
26614406
4.

Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

Pun PH, Abdalla S, Block GA, Chertow GM, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Goodman WG, Herzog CA, London GM, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Middleton JP.

Hemodial Int. 2015 Nov 13. doi: 10.1111/hdi.12382. [Epub ahead of print]

PMID:
26564024
5.

The Circadian Clock Gene Period1 Connects the Molecular Clock to Neural Activity in the Suprachiasmatic Nucleus.

Kudo T, Block GD, Colwell CS.

ASN Neuro. 2015 Nov 9;7(6). pii: 1759091415610761. doi: 10.1177/1759091415610761. Print 2015 Dec.

6.

Diabetes Prevention and Weight Loss with a Fully Automated Behavioral Intervention by Email, Web, and Mobile Phone: A Randomized Controlled Trial Among Persons with Prediabetes.

Block G, Azar KM, Romanelli RJ, Block TJ, Hopkins D, Carpenter HA, Dolginsky MS, Hudes ML, Palaniappan LP, Block CH.

J Med Internet Res. 2015 Oct 23;17(10):e240. doi: 10.2196/jmir.4897.

7.

Age-Related Changes in the Circadian System Unmasked by Constant Conditions(1,2,3).

Nakamura TJ, Nakamura W, Tokuda IT, Ishikawa T, Kudo T, Colwell CS, Block GD.

eNeuro. 2015 Sep 22;2(4). pii: ENEURO.0064-15.2015. doi: 10.1523/ENEURO.0064-15.2015. eCollection 2015 Jul-Aug.

8.

Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study.

Selamet U, Tighiouart H, Sarnak MJ, Beck G, Levey AS, Block G, Ix JH.

Kidney Int. 2015 Sep 30. doi: 10.1038/ki.2015.284. [Epub ahead of print]

PMID:
26422502
9.

Understanding barriers to home-based and self-care in-center hemodialysis.

Yau M, Carver M, Alvarez L, Block GA, Chertow GM.

Hemodial Int. 2015 Sep 28. doi: 10.1111/hdi.12357. [Epub ahead of print]

PMID:
26415746
10.

Correction: Genomic Comparison of Non-Typhoidal Salmonella enterica Serovars Typhimurium, Enteritidis, Heidelberg, Hadar and Kentucky Isolates from Broiler Chickens.

Dhanani AS, Block G, Dewar K, Forgetta V, Topp E, Beiko RG, Diarra MS.

PLoS One. 2015 Sep 9;10(9):e0137697. doi: 10.1371/journal.pone.0137697. eCollection 2015. No abstract available.

11.

Exposure to Bovine Leukemia Virus Is Associated with Breast Cancer: A Case-Control Study.

Buehring GC, Shen HM, Jensen HM, Jin DL, Hudes M, Block G.

PLoS One. 2015 Sep 2;10(9):e0134304. doi: 10.1371/journal.pone.0134304. eCollection 2015.

12.

Recovery from Age-Related Infertility under Environmental Light-Dark Cycles Adjusted to the Intrinsic Circadian Period.

Takasu NN, Nakamura TJ, Tokuda IT, Todo T, Block GD, Nakamura W.

Cell Rep. 2015 Sep 1;12(9):1407-13. doi: 10.1016/j.celrep.2015.07.049. Epub 2015 Aug 20.

13.

Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy.

Wetmore JB, Liu J, Do TP, Lowe KA, Ishani A, Bradbury BD, Block GA, Collins AJ.

Nephrol Dial Transplant. 2016 Jan;31(1):103-11. doi: 10.1093/ndt/gfv291. Epub 2015 Aug 19.

PMID:
26292694
14.

Genomic Comparison of Non-Typhoidal Salmonella enterica Serovars Typhimurium, Enteritidis, Heidelberg, Hadar and Kentucky Isolates from Broiler Chickens.

Dhanani AS, Block G, Dewar K, Forgetta V, Topp E, Beiko RG, Diarra MS.

PLoS One. 2015 Jun 17;10(6):e0128773. doi: 10.1371/journal.pone.0128773. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0137697.

15.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*.

Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9.

PMID:
26059012
16.

The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial.

Chang TI, Abdalla S, London GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Dehmel B, Goodman WG, Chertow GM.

J Hum Hypertens. 2015 Jun 4. doi: 10.1038/jhh.2015.56. [Epub ahead of print]

PMID:
26040438
17.

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.

Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block GA.

J Am Soc Nephrol. 2015 Oct;26(10):2328-39. doi: 10.1681/ASN.2015020117. Epub 2015 May 12. Review.

PMID:
25967123
18.

Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.

Miller RG, Block G, Katz JS, Barohn RJ, Gopalakrishnan V, Cudkowicz M, Zhang JR, McGrath MS, Ludington E, Appel SH, Azhir A; Phase 2 Trial NP001 Investigators.

Neurol Neuroimmunol Neuroinflamm. 2015 Apr 9;2(3):e100. doi: 10.1212/NXI.0000000000000100. eCollection 2015 Jun.

19.

Refining the definition of clinically important mineral and bone disorder in hemodialysis patients.

Danese MD, Halperin M, Lowe KA, Bradbury BD, Do TP, Block GA.

Nephrol Dial Transplant. 2015 Aug;30(8):1336-44. doi: 10.1093/ndt/gfv034. Epub 2015 Mar 27.

20.

A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients.

Bell G, Huang S, Martin KJ, Block GA.

Curr Med Res Opin. 2015 May;31(5):943-52. doi: 10.1185/03007995.2015.1031731.

PMID:
25786369
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk